Evaluating the impact of faculty performance appraisal systems on curriculum development and laboratory innovation in pharmaceutical education

BACKGROUND: Pharmaceutical education is undergoing significant transformation, requiring faculty to engage in curriculum innovation, technology-enhanced teaching, and advanced laboratory management. However, Faculty Performance Appraisal Systems (FPAS) in Indian pharmacy institutions, particularly in Tamil Nadu, continue to prioritize traditional quantitative metrics, such as publication counts, grant acquisition, teaching workload, and compliance-oriented performance indicators, often overlooking contributions to curriculum development and laboratory modernization. FPAS are commonly used institutional evaluation mechanisms in Indian higher education for faculty appraisal, promotion, and quality assurance. This misalignment may hinder pedagogical innovation and faculty motivation. METHODS: A contextual and institutional analysis was conducted across pharmacy education settings in Tamil Nadu covering 12 institutions and 412 faculty respondents to examine existing FPAS frameworks and their alignment with contemporary curricular and laboratory expectations. A cross-sectional quantitative survey design was adopted. The study analyzed appraisal criteria, institutional practices, and faculty perceptions with particular focus on FPAS rigor, transparency, fairness, laboratory excellence, pedagogical innovation, and educational technology adoption, to identify gaps between evaluation mechanisms and educational innovation requirements. The analysis also aimed to generate evidence-based directions for strengthening appraisal practices. RESULTS: The findings revealed that prevailing appraisal systems inadequately recognize curriculum redesign, pharmaceutical education technologies, and laboratory-based innovations. Overreliance on quantitative indicators and subjective assessments was associated with reduced faculty engagement, limited adoption of innovative teaching methodologies, and stagnation in curriculum advancement. Regression and structural equation modelling indicated significant positive associations between FPAS rigor and pedagogical innovation (β = 0.462, p < 0.001), FPAS transparency and laboratory excellence (β = 0.517, p < 0.001), and FPAS fairness and faculty motivation (β = 0.498, p < 0.001). CONCLUSION: The study proposes a restructured, multidimensional FPAS framework that formally integrates curriculum development outcomes, educational technologies, and laboratory excellence into faculty evaluation. By adopting transparent and developmental appraisal benchmarks, institutions can foster sustained pedagogical innovation and research-informed teaching. This approach offers practical guidance for academic leaders and policymakers aiming to strengthen curriculum quality in pharmaceutical education.